| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 3.01e-11 | 38 | 111 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.97e-08 | 118 | 111 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | ethanol binding | 3.30e-06 | 6 | 111 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 RAB35 MYH4 MYH7 ARF1 ARF3 ARF4 ARF5 ATP8A1 RAB24 RRAGD ASCC3 ATP1A4 DNAH6 RAB5B | 2.53e-05 | 775 | 111 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH13 MYH7B ATP8A1 HELZ ASCC3 ATP1A4 DNAH6 | 3.68e-05 | 614 | 111 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | 3.99e-05 | 227 | 111 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.37e-05 | 230 | 111 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 RAB35 MYH4 MYH7 ARF1 ARF3 ARF4 ARF5 ATP8A1 RAB24 RRAGD ASCC3 ATP1A4 DNAH6 RAB5B | 6.27e-05 | 839 | 111 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 RAB35 MYH4 MYH7 ARF1 ARF3 ARF4 ARF5 ATP8A1 RAB24 RRAGD ASCC3 ATP1A4 DNAH6 RAB5B | 6.35e-05 | 840 | 111 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 RAB35 MYH4 MYH7 ARF1 ARF3 ARF4 ARF5 ATP8A1 RAB24 RRAGD ASCC3 ATP1A4 DNAH6 RAB5B | 6.35e-05 | 840 | 111 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | actin binding | 7.38e-05 | 479 | 111 | 11 | GO:0003779 | |
| GeneOntologyMolecularFunction | phospholipase D activator activity | 9.15e-05 | 3 | 111 | 2 | GO:1990583 | |
| GeneOntologyMolecularFunction | alcohol binding | 2.63e-04 | 102 | 111 | 5 | GO:0043178 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A GPR89B SLC26A4 TRPC5 BAK1 SLCO1B3 CACHD1 PKD1L3 SLC44A4 KCNH6 SIDT2 ATP8A1 MFSD14B GPR89A ATP1A4 SLC16A7 SLC26A6 | 2.72e-04 | 1180 | 111 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 3.11e-04 | 24 | 111 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | GTP binding | 3.76e-04 | 397 | 111 | 9 | GO:0005525 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 3.96e-04 | 26 | 111 | 3 | GO:0004022 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity | 4.53e-04 | 6 | 111 | 2 | GO:0043813 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 6.08e-04 | 30 | 111 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | GTPase activity | 6.40e-04 | 341 | 111 | 8 | GO:0003924 | |
| GeneOntologyMolecularFunction | NAD binding | 7.33e-04 | 73 | 111 | 4 | GO:0051287 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A GPR89B SLC26A4 TRPC5 BAK1 SLCO1B3 CACHD1 PKD1L3 SLC44A4 KCNH6 SIDT2 ATP8A1 MFSD14B GPR89A ATP1A4 SLC16A7 SLC26A6 | 7.47e-04 | 1289 | 111 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 7.73e-04 | 439 | 111 | 9 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 7.73e-04 | 439 | 111 | 9 | GO:0019001 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 1.34e-03 | 10 | 111 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | secondary active sulfate transmembrane transporter activity | 1.63e-03 | 11 | 111 | 2 | GO:0008271 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 2.29e-03 | 13 | 111 | 2 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 2.29e-03 | 13 | 111 | 2 | GO:0140829 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate 5-phosphatase activity | 2.29e-03 | 13 | 111 | 2 | GO:0034595 | |
| GeneOntologyMolecularFunction | GDP binding | 2.62e-03 | 103 | 111 | 4 | GO:0019003 | |
| GeneOntologyMolecularFunction | channel activity | CACNA1A GPR89B TRPC5 BAK1 CACHD1 PKD1L3 KCNH6 GPR89A SLC26A6 | 2.64e-03 | 525 | 111 | 9 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A GPR89B TRPC5 BAK1 CACHD1 PKD1L3 KCNH6 GPR89A SLC26A6 | 2.68e-03 | 526 | 111 | 9 | GO:0022803 |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 3.49e-03 | 16 | 111 | 2 | GO:0015116 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 3.49e-03 | 16 | 111 | 2 | GO:0106018 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.50e-03 | 182 | 111 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.67e-03 | 184 | 111 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 3.94e-03 | 17 | 111 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.12e-03 | 459 | 111 | 8 | GO:0005216 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 1.19e-08 | 15 | 111 | 5 | GO:0030049 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 3.34e-08 | 18 | 111 | 5 | GO:0033275 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 1.52e-07 | 3 | 111 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 1.51e-06 | 5 | 111 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | regulation of pH | 3.90e-06 | 120 | 111 | 7 | GO:0006885 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.68e-06 | 127 | 111 | 7 | GO:0070252 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.92e-05 | 153 | 111 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | muscle contraction | 6.08e-05 | 400 | 111 | 10 | GO:0006936 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 6.25e-05 | 40 | 111 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | behavior | CACNA1A HTR1D SPG11 KAT2A ARF4 ADH1A ADH1B ADH1C TGM4 NTAN1 ATP8A1 CFAP20 VPS13A ALDH1A3 CSMD1 | 8.56e-05 | 891 | 111 | 15 | GO:0007610 |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 9.76e-05 | 17 | 111 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 9.76e-05 | 17 | 111 | 3 | GO:0006068 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CA12 CACNA1A GPR89B DMXL2 ANK2 MYH7B SLC26A4 TRPC5 BAK1 ARF1 GPR89A ATP1A4 SLC26A6 | 1.08e-04 | 705 | 111 | 13 | GO:0055080 |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.17e-04 | 18 | 111 | 3 | GO:0006067 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CA12 CACNA1A GPR89B DMXL2 ANK2 MYH7B SLC26A4 TRPC5 BAK1 LYST ARF1 SIDT2 GCLC DISP3 GPR89A CSMD1 ATP1A4 SLC26A6 | 1.17e-04 | 1249 | 111 | 18 | GO:0048878 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CA12 CACNA1A GPR89B DMXL2 ANK2 MYH7B SLC26A4 TRPC5 BAK1 ARF1 GPR89A ATP1A4 SLC26A6 | 1.27e-04 | 717 | 111 | 13 | GO:0050801 |
| GeneOntologyBiologicalProcess | retinol metabolic process | 1.90e-04 | 53 | 111 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 2.17e-04 | 101 | 111 | 5 | GO:0030641 | |
| GeneOntologyBiologicalProcess | neuromuscular process | 2.18e-04 | 225 | 111 | 7 | GO:0050905 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.48e-04 | 23 | 111 | 3 | GO:0034310 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 2.84e-04 | 5 | 111 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1A GPR89B DMXL2 ANK2 MYH7B TRPC5 BAK1 ARF1 GPR89A ATP1A4 SLC26A6 | 4.58e-04 | 611 | 111 | 11 | GO:0030003 |
| GeneOntologyBiologicalProcess | lytic vacuole organization | 4.63e-04 | 119 | 111 | 5 | GO:0080171 | |
| GeneOntologyBiologicalProcess | lysosome organization | 4.63e-04 | 119 | 111 | 5 | GO:0007040 | |
| GeneOntologyCellularComponent | myosin filament | 4.91e-13 | 25 | 111 | 8 | GO:0032982 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.08e-12 | 16 | 111 | 7 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin II complex | 1.39e-12 | 28 | 111 | 8 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 8.67e-10 | 59 | 111 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | myofibril | 1.98e-06 | 273 | 111 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.39e-06 | 290 | 111 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | dense core granule | 1.19e-05 | 56 | 111 | 5 | GO:0031045 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 3.89e-05 | 36 | 111 | 4 | GO:0098992 | |
| GeneOntologyCellularComponent | sarcomere | 5.56e-05 | 249 | 111 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 3.16e-04 | 111 | 111 | 5 | GO:0001750 | |
| GeneOntologyCellularComponent | sperm midpiece | 3.74e-04 | 64 | 111 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GPR89B RAB35 DMXL2 VPS13C OCRL TICAM2 PIKFYVE ATP8A1 RAB24 CADPS SCARB2 TLR4 VPS13A DISP3 GPR89A RAB5B SLC26A6 | 5.22e-04 | 1307 | 111 | 17 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | GPR89B RAB35 DMXL2 VPS13C OCRL TICAM2 PIKFYVE ATP8A1 RAB24 CADPS SCARB2 TLR4 VPS13A DISP3 GPR89A RAB5B SLC26A6 | 6.09e-04 | 1325 | 111 | 17 | GO:0012506 |
| GeneOntologyCellularComponent | transporter complex | CACNA1A GPR89B TRPC5 CACHD1 PKD1L3 KCNH6 ATP8A1 GPR89A ATP1A4 SLC26A6 | 7.01e-04 | 550 | 111 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 8.82e-04 | 139 | 111 | 5 | GO:0097733 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 9.29e-04 | 378 | 111 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | rod photoreceptor outer segment | 9.82e-04 | 9 | 111 | 2 | GO:0120200 | |
| GeneOntologyCellularComponent | dense core granule membrane | 1.22e-03 | 10 | 111 | 2 | GO:0032127 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.35e-03 | 153 | 111 | 5 | GO:0097731 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1A GPR89B TRPC5 CACHD1 PKD1L3 KCNH6 GPR89A ATP1A4 SLC26A6 | 1.90e-03 | 523 | 111 | 9 | GO:1902495 |
| GeneOntologyCellularComponent | A band | 2.67e-03 | 52 | 111 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | cilium | EVC OCRL FSIP2 EYS ARR3 GUCY2F CFAP20 VPS13A ATP1A4 DNAH6 HYDIN SLC26A6 | 2.92e-03 | 898 | 111 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 3.21e-03 | 114 | 111 | 4 | GO:0005798 | |
| MousePheno | abnormal ethanol metabolism | 5.44e-06 | 6 | 92 | 3 | MP:0005443 | |
| MousePheno | abnormal retinol metabolism | 9.47e-06 | 7 | 92 | 3 | MP:0005444 | |
| MousePheno | enhanced behavioral response to xenobiotic | 8.92e-05 | 69 | 92 | 5 | MP:0009746 | |
| MousePheno | abnormal vitamin metabolism | 1.19e-04 | 15 | 92 | 3 | MP:0013244 | |
| MousePheno | abnormal vitamin or vitamin cofactor metabolism | 1.19e-04 | 15 | 92 | 3 | MP:0013274 | |
| MousePheno | abnormal vitamin A metabolism | 1.19e-04 | 15 | 92 | 3 | MP:0011233 | |
| MousePheno | abnormal miniature excitatory postsynaptic current amplitude | 1.19e-04 | 15 | 92 | 3 | MP:0014371 | |
| MousePheno | enhanced behavioral response to alcohol | 1.45e-04 | 16 | 92 | 3 | MP:0009751 | |
| MousePheno | decreased endocochlear potential | 2.10e-04 | 18 | 92 | 3 | MP:0004411 | |
| Domain | Myosin_N | 6.45e-15 | 15 | 109 | 8 | PF02736 | |
| Domain | Myosin_N | 6.45e-15 | 15 | 109 | 8 | IPR004009 | |
| Domain | Myosin_tail_1 | 4.32e-14 | 18 | 109 | 8 | PF01576 | |
| Domain | Myosin_tail | 4.32e-14 | 18 | 109 | 8 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 7.43e-14 | 19 | 109 | 8 | IPR027401 | |
| Domain | - | 7.43e-14 | 19 | 109 | 8 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 4.38e-11 | 38 | 109 | 8 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.38e-11 | 38 | 109 | 8 | PS51456 | |
| Domain | Myosin_head | 4.38e-11 | 38 | 109 | 8 | PF00063 | |
| Domain | MYSc | 4.38e-11 | 38 | 109 | 8 | SM00242 | |
| Domain | IQ | 1.03e-09 | 81 | 109 | 9 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.68e-09 | 90 | 109 | 9 | IPR000048 | |
| Domain | IQ | 3.59e-09 | 93 | 109 | 9 | PS50096 | |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH3 RAB35 MYH4 MYH6 MYH7 MYH13 MYH7B ARF1 ARF3 ARF4 ARF5 RAB24 RRAGD HELZ CAMTA1 ASCC3 DNAH6 RAB5B HYDIN | 1.70e-08 | 848 | 109 | 21 | IPR027417 |
| Domain | IQ | 1.86e-07 | 71 | 109 | 7 | PF00612 | |
| Domain | PH_BEACH | 3.82e-06 | 6 | 109 | 3 | PF14844 | |
| Domain | ADH_Zn_CS | 1.06e-05 | 8 | 109 | 3 | IPR002328 | |
| Domain | ADH_ZINC | 1.06e-05 | 8 | 109 | 3 | PS00059 | |
| Domain | PH-BEACH_dom | 1.06e-05 | 8 | 109 | 3 | IPR023362 | |
| Domain | - | 1.06e-05 | 8 | 109 | 3 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.06e-05 | 8 | 109 | 3 | PS51783 | |
| Domain | BEACH | 1.58e-05 | 9 | 109 | 3 | PS50197 | |
| Domain | Beach | 1.58e-05 | 9 | 109 | 3 | PF02138 | |
| Domain | - | 1.58e-05 | 9 | 109 | 3 | 1.10.1540.10 | |
| Domain | Beach | 1.58e-05 | 9 | 109 | 3 | SM01026 | |
| Domain | BEACH_dom | 1.58e-05 | 9 | 109 | 3 | IPR000409 | |
| Domain | ARF | 2.33e-05 | 29 | 109 | 4 | PS51417 | |
| Domain | Small_GTPase_ARF | 2.33e-05 | 29 | 109 | 4 | IPR024156 | |
| Domain | Arf | 3.06e-05 | 31 | 109 | 4 | PF00025 | |
| Domain | Small_GTPase_ARF/SAR | 3.94e-05 | 33 | 109 | 4 | IPR006689 | |
| Domain | Small_GTPase | 4.26e-05 | 160 | 109 | 7 | IPR001806 | |
| Domain | Small_GTP-bd_dom | 5.59e-05 | 167 | 109 | 7 | IPR005225 | |
| Domain | VPS13 | 1.01e-04 | 3 | 109 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.01e-04 | 3 | 109 | 2 | PF16910 | |
| Domain | VPS13 | 1.01e-04 | 3 | 109 | 2 | PF16908 | |
| Domain | VPS13_N2 | 1.01e-04 | 3 | 109 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.01e-04 | 3 | 109 | 2 | IPR031642 | |
| Domain | PKS_ER | 1.02e-04 | 16 | 109 | 3 | IPR020843 | |
| Domain | ADH_N | 1.02e-04 | 16 | 109 | 3 | PF08240 | |
| Domain | PKS_ER | 1.02e-04 | 16 | 109 | 3 | SM00829 | |
| Domain | ADH_N | 1.02e-04 | 16 | 109 | 3 | IPR013154 | |
| Domain | - | 1.48e-04 | 18 | 109 | 3 | 3.90.180.10 | |
| Domain | ADH_zinc_N | 1.75e-04 | 19 | 109 | 3 | PF00107 | |
| Domain | ADH_SF_Zn-type | 1.75e-04 | 19 | 109 | 3 | IPR002085 | |
| Domain | ADH_C | 1.75e-04 | 19 | 109 | 3 | IPR013149 | |
| Domain | SHR-BD | 2.01e-04 | 4 | 109 | 2 | IPR009543 | |
| Domain | VPS13_C | 2.01e-04 | 4 | 109 | 2 | PF16909 | |
| Domain | VPS13_C | 2.01e-04 | 4 | 109 | 2 | IPR031645 | |
| Domain | SHR-BD | 2.01e-04 | 4 | 109 | 2 | PF06650 | |
| Domain | - | 2.36e-04 | 95 | 109 | 5 | 2.60.120.200 | |
| Domain | VWA | 3.19e-04 | 56 | 109 | 4 | PF00092 | |
| Domain | Autophagy-rel_C | 3.34e-04 | 5 | 109 | 2 | IPR015412 | |
| Domain | ATG_C | 3.34e-04 | 5 | 109 | 2 | PF09333 | |
| Domain | DUF4704 | 3.34e-04 | 5 | 109 | 2 | IPR031570 | |
| Domain | DUF4704 | 3.34e-04 | 5 | 109 | 2 | PF15787 | |
| Domain | GroES-like | 3.58e-04 | 24 | 109 | 3 | IPR011032 | |
| Domain | Ig_E-set | 3.59e-04 | 104 | 109 | 5 | IPR014756 | |
| Domain | S04_transporter_CS | 6.95e-04 | 7 | 109 | 2 | IPR018045 | |
| Domain | - | 9.23e-04 | 74 | 109 | 4 | 3.40.50.410 | |
| Domain | Chorein_N | 9.24e-04 | 8 | 109 | 2 | PF12624 | |
| Domain | VPS13_N | 9.24e-04 | 8 | 109 | 2 | IPR026854 | |
| Domain | VWFA | 1.35e-03 | 82 | 109 | 4 | PS50234 | |
| Domain | - | RAB35 ARF1 ARF3 ARF4 ARF5 RAB24 RRAGD HELZ ASCC3 DNAH6 RAB5B HYDIN | 1.36e-03 | 746 | 109 | 12 | 3.40.50.300 |
| Domain | SLC26A | 1.47e-03 | 10 | 109 | 2 | PS01130 | |
| Domain | VWA | 1.48e-03 | 84 | 109 | 4 | SM00327 | |
| Domain | STAS | 1.79e-03 | 11 | 109 | 2 | PS50801 | |
| Domain | STAS | 1.79e-03 | 11 | 109 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 1.79e-03 | 11 | 109 | 2 | IPR001902 | |
| Domain | STAS_dom | 1.79e-03 | 11 | 109 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 1.79e-03 | 11 | 109 | 2 | IPR011547 | |
| Domain | - | 1.79e-03 | 11 | 109 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 1.79e-03 | 11 | 109 | 2 | PF00916 | |
| Domain | VWF_A | 2.70e-03 | 99 | 109 | 4 | IPR002035 | |
| Domain | NAD/diacylglycerol_kinase | 4.33e-03 | 17 | 109 | 2 | IPR016064 | |
| Domain | Laminin_G | 4.73e-03 | 58 | 109 | 3 | IPR001791 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 5.35e-09 | 70 | 80 | 8 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 7.86e-07 | 132 | 80 | 8 | M11355 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 2.77e-06 | 18 | 80 | 4 | M645 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | 2.77e-06 | 18 | 80 | 4 | MM14642 | |
| Pathway | REACTOME_ABACAVIR_ADME | 9.66e-06 | 8 | 80 | 3 | MM14869 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.78e-05 | 28 | 80 | 4 | MM15188 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 2.05e-05 | 10 | 80 | 3 | MM15833 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 2.69e-05 | 31 | 80 | 4 | M39714 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 2.81e-05 | 11 | 80 | 3 | MM15405 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 3.73e-05 | 12 | 80 | 3 | M14663 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 7.62e-05 | 15 | 80 | 3 | M39717 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 9.14e-05 | 42 | 80 | 4 | M16743 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND | 9.34e-05 | 16 | 80 | 3 | M26947 | |
| Pathway | WP_RETINOL_METABOLISM | 1.10e-04 | 44 | 80 | 4 | MM15851 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND | 1.60e-04 | 19 | 80 | 3 | MM14555 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.68e-04 | 49 | 80 | 4 | MM15186 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.51e-04 | 22 | 80 | 3 | M27445 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.81e-04 | 102 | 80 | 5 | M27648 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY | 2.87e-04 | 23 | 80 | 3 | MM15176 | |
| Pathway | REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY | 4.16e-04 | 26 | 80 | 3 | M27434 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 4.18e-04 | 62 | 80 | 4 | M11521 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 6.64e-04 | 70 | 80 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 7.38e-04 | 72 | 80 | 4 | M9257 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 8.56e-04 | 196 | 80 | 6 | MM14591 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 9.05e-04 | 76 | 80 | 4 | M9052 | |
| Pathway | REACTOME_PI_METABOLISM | 9.50e-04 | 77 | 80 | 4 | MM14590 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY | 1.12e-03 | 9 | 80 | 2 | M47598 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.12e-03 | 9 | 80 | 2 | M27344 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.12e-03 | 9 | 80 | 2 | MM15084 | |
| Pathway | REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH | 1.12e-03 | 9 | 80 | 2 | M27192 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 1.25e-03 | 211 | 80 | 6 | M649 | |
| Pathway | REACTOME_PI_METABOLISM | 1.32e-03 | 84 | 80 | 4 | M676 | |
| Pathway | REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH | 1.39e-03 | 10 | 80 | 2 | MM14905 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 1.72e-03 | 42 | 80 | 3 | M699 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.84e-03 | 43 | 80 | 3 | M27443 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.92e-03 | 156 | 80 | 5 | M27097 | |
| Pathway | WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY | 2.02e-03 | 12 | 80 | 2 | M45558 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 2.24e-03 | 46 | 80 | 3 | M48317 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.24e-03 | 46 | 80 | 3 | M198 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.32e-03 | 98 | 80 | 4 | MM15352 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.50e-03 | 100 | 80 | 4 | M27650 | |
| Pubmed | 6.43e-15 | 7 | 111 | 6 | 35210422 | ||
| Pubmed | 6.43e-15 | 7 | 111 | 6 | 16819597 | ||
| Pubmed | 1.81e-12 | 6 | 111 | 5 | 1728586 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 1.81e-12 | 6 | 111 | 5 | 10077619 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.81e-12 | 6 | 111 | 5 | 10588881 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 6.32e-12 | 7 | 111 | 5 | 29758057 | |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 7.19e-12 | 16 | 111 | 6 | 19922871 | |
| Pubmed | 1.68e-11 | 8 | 111 | 5 | 3864153 | ||
| Pubmed | 9.83e-11 | 4 | 111 | 4 | 10388558 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.38e-10 | 11 | 111 | 5 | 16024798 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 3.81e-10 | 13 | 111 | 5 | 8404542 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 4.90e-10 | 5 | 111 | 4 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 4.90e-10 | 5 | 111 | 4 | 12919077 | |
| Pubmed | ADP-ribosylation factor is functionally and physically associated with the Golgi complex. | 4.90e-10 | 5 | 111 | 4 | 2105501 | |
| Pubmed | 4.90e-10 | 5 | 111 | 4 | 6196357 | ||
| Pubmed | 5.92e-10 | 14 | 111 | 5 | 27184118 | ||
| Pubmed | 5.92e-10 | 14 | 111 | 5 | 24938781 | ||
| Pubmed | 6.36e-10 | 31 | 111 | 6 | 21985497 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 8.85e-10 | 15 | 111 | 5 | 24852826 | |
| Pubmed | An Arf/Rab cascade controls the growth and invasiveness of glioblastoma. | 1.47e-09 | 6 | 111 | 4 | 33443570 | |
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 8947846 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 6.81e-09 | 8 | 111 | 4 | 14667415 | |
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 26993635 | ||
| Pubmed | 6.81e-09 | 8 | 111 | 4 | 8195219 | ||
| Pubmed | 7.62e-09 | 22 | 111 | 5 | 24301466 | ||
| Pubmed | 1.22e-08 | 9 | 111 | 4 | 31960486 | ||
| Pubmed | 2.03e-08 | 10 | 111 | 4 | 10828067 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 IPO7 MYH13 MYH7B LAMA5 AHSA1 ARF4 NCAPD2 RAB5B | 2.07e-08 | 647 | 111 | 14 | 26618866 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYH3 RAB35 COL6A3 MYH13 VPS13C SLC26A4 LAMA5 PM20D1 PKD1L3 SLC44A4 AHSA1 TGM4 EYS CFAP20 SCARB2 PIP RAB5B | 2.49e-08 | 1016 | 111 | 17 | 19056867 |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 3.16e-08 | 3 | 111 | 3 | 26059207 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 11960985 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 2474823 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 3.16e-08 | 3 | 111 | 3 | 23772048 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 8163197 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 1447192 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 3.16e-08 | 3 | 111 | 3 | 24787690 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 20921225 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 3011597 | ||
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 3.16e-08 | 3 | 111 | 3 | 1694848 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 6756216 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 37806378 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 7840644 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 3.16e-08 | 3 | 111 | 3 | 15670660 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 8018987 | ||
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 3.16e-08 | 3 | 111 | 3 | 33586683 | |
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 3.16e-08 | 3 | 111 | 3 | 3157987 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 23783033 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 2169444 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 21470888 | ||
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 3.16e-08 | 3 | 111 | 3 | 8486690 | |
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 3.16e-08 | 3 | 111 | 3 | 16801720 | |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 3.16e-08 | 3 | 111 | 3 | 10424757 | |
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 3.16e-08 | 3 | 111 | 3 | 1939265 | |
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 3.16e-08 | 3 | 111 | 3 | 1371481 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 2347582 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 3.16e-08 | 3 | 111 | 3 | 7748347 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 3006456 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 3.16e-08 | 3 | 111 | 3 | 9145544 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 3.16e-08 | 3 | 111 | 3 | 6816803 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 3.16e-08 | 3 | 111 | 3 | 15554233 | |
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 35354963 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 6370228 | ||
| Pubmed | 3.16e-08 | 3 | 111 | 3 | 2935875 | ||
| Pubmed | 3.19e-08 | 11 | 111 | 4 | 18310078 | ||
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 3.19e-08 | 11 | 111 | 4 | 29168801 | |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 6.68e-08 | 33 | 111 | 5 | 32094117 | |
| Pubmed | 9.60e-08 | 14 | 111 | 4 | 33742095 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 8491770 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 20357587 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 8813054 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 1985022 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.26e-07 | 4 | 111 | 3 | 11029314 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 12631290 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 2893758 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 19948655 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.26e-07 | 4 | 111 | 3 | 18417546 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11893554 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 29663519 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 12851412 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 9733106 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 36224745 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 11023856 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 9202249 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 19618839 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 1.26e-07 | 4 | 111 | 3 | 3996732 | |
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 9241435 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 10880953 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 9002638 | ||
| Pubmed | 1.26e-07 | 4 | 111 | 3 | 15193143 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 1.31e-07 | 15 | 111 | 4 | 9726281 | |
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 2.26e-07 | 17 | 111 | 4 | 22351927 | |
| Pubmed | 2.26e-07 | 17 | 111 | 4 | 16124007 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 9038142 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 11836246 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 8621625 | ||
| Pubmed | 3.15e-07 | 5 | 111 | 3 | 1316195 | ||
| Interaction | ASAH2 interactions | 1.20e-08 | 6 | 109 | 4 | int:ASAH2 | |
| Interaction | TMEM260 interactions | 5.58e-07 | 13 | 109 | 4 | int:TMEM260 | |
| Interaction | RSPH6A interactions | 1.04e-06 | 34 | 109 | 5 | int:RSPH6A | |
| Interaction | PRKAG2 interactions | 1.82e-06 | 68 | 109 | 6 | int:PRKAG2 | |
| Interaction | DENND1B interactions | 4.51e-06 | 21 | 109 | 4 | int:DENND1B | |
| Interaction | ARFIP1 interactions | 8.32e-06 | 134 | 109 | 7 | int:ARFIP1 | |
| Interaction | AP3S2 interactions | 1.50e-05 | 28 | 109 | 4 | int:AP3S2 | |
| Interaction | ABTB2 interactions | 1.82e-05 | 101 | 109 | 6 | int:ABTB2 | |
| Interaction | TSPAN33 interactions | 2.69e-05 | 65 | 109 | 5 | int:TSPAN33 | |
| Interaction | LZTR1 interactions | 3.11e-05 | 111 | 109 | 6 | int:LZTR1 | |
| Interaction | CDK3 interactions | 3.62e-05 | 114 | 109 | 6 | int:CDK3 | |
| Interaction | SLC39A3 interactions | 3.86e-05 | 70 | 109 | 5 | int:SLC39A3 | |
| Interaction | ACTN2 interactions | 4.03e-05 | 171 | 109 | 7 | int:ACTN2 | |
| Interaction | HSPB8 interactions | 4.19e-05 | 172 | 109 | 7 | int:HSPB8 | |
| Interaction | ADH1B interactions | 4.23e-05 | 13 | 109 | 3 | int:ADH1B | |
| Interaction | STK3 interactions | 5.79e-05 | 181 | 109 | 7 | int:STK3 | |
| Interaction | AURKC interactions | 8.49e-05 | 43 | 109 | 4 | int:AURKC | |
| Interaction | LATS1 interactions | 1.38e-04 | 440 | 109 | 10 | int:LATS1 | |
| Interaction | WDR7 interactions | 1.50e-04 | 93 | 109 | 5 | int:WDR7 | |
| Interaction | MYH3 interactions | 1.79e-04 | 52 | 109 | 4 | int:MYH3 | |
| Interaction | MYH8 interactions | 1.79e-04 | 52 | 109 | 4 | int:MYH8 | |
| Interaction | AP4E1 interactions | 2.08e-04 | 54 | 109 | 4 | int:AP4E1 | |
| Interaction | STK4 interactions | 2.28e-04 | 159 | 109 | 6 | int:STK4 | |
| Interaction | ARFIP2 interactions | 2.54e-04 | 104 | 109 | 5 | int:ARFIP2 | |
| Cytoband | 4q23 | 1.52e-05 | 20 | 111 | 3 | 4q23 | |
| Cytoband | 6q16 | 5.77e-05 | 5 | 111 | 2 | 6q16 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 1.01e-04 | 37 | 111 | 3 | chr4q23 | |
| Cytoband | 17p13.1 | 2.01e-04 | 118 | 111 | 4 | 17p13.1 | |
| Cytoband | 4q21.23 | 4.44e-04 | 13 | 111 | 2 | 4q21.23 | |
| Cytoband | 12q13 | 6.98e-04 | 71 | 111 | 3 | 12q13 | |
| Cytoband | 16q22.2 | 1.30e-03 | 22 | 111 | 2 | 16q22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.58e-03 | 346 | 111 | 5 | chr17p13 | |
| Cytoband | 4q35.1 | 3.46e-03 | 36 | 111 | 2 | 4q35.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q21 | 4.20e-03 | 133 | 111 | 3 | chr4q21 | |
| GeneFamily | Myosin heavy chains | 3.35e-16 | 15 | 74 | 8 | 1098 | |
| GeneFamily | Alcohol dehydrogenases | 3.63e-06 | 8 | 74 | 3 | 397 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 5.43e-06 | 9 | 74 | 3 | 1230 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 7.48e-06 | 31 | 74 | 4 | 357 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 2.40e-03 | 65 | 74 | 3 | 388 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-07 | 184 | 111 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-07 | 184 | 111 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-07 | 184 | 111 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Calb1_(Superficial_layer_pyramidal_cells--Layer_2/3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.62e-07 | 126 | 111 | 6 | 7dcc79bf35482e8e5e5a1de7279ba080edb70522 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.43e-06 | 77 | 111 | 5 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Lypd1_(CA1_Principal_cells_(Anterior))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.21e-06 | 84 | 111 | 5 | 52d167614afa9b056f2934142d3250fe5e70e806 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-06 | 162 | 111 | 6 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.66e-06 | 165 | 111 | 6 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 4.20e-06 | 169 | 111 | 6 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.97e-06 | 174 | 111 | 6 | 019eae059bd9eb107dee8f0d0f574ca36c2c26e1 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.05e-06 | 185 | 111 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.05e-06 | 185 | 111 | 6 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.97e-06 | 189 | 111 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.97e-06 | 189 | 111 | 6 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.97e-06 | 189 | 111 | 6 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.21e-06 | 190 | 111 | 6 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.21e-06 | 190 | 111 | 6 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.21e-06 | 190 | 111 | 6 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.31e-06 | 110 | 111 | 5 | 5496c92932195386025254b9129d69b12c8e3340 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.31e-06 | 110 | 111 | 5 | 41306a2d4a5a39569437eb123e47f98ef8afab24 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Inhibitory_Neuron.Gad1Gad2.Pnoc_(Fast-spiking_interneuron,_Pvalb+/Pnoc+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.31e-06 | 110 | 111 | 5 | 1fe08060248b25329f73b80d74435c108bee1359 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 8.46e-06 | 191 | 111 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.46e-06 | 191 | 111 | 6 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.98e-06 | 193 | 111 | 6 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.25e-06 | 194 | 111 | 6 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.07e-05 | 199 | 111 | 6 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-05 | 199 | 111 | 6 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.10e-05 | 200 | 111 | 6 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 200 | 111 | 6 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.10e-05 | 200 | 111 | 6 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-05 | 200 | 111 | 6 | 6ce8e2cf689523993d909a27daec3d6a5824d13c | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-05 | 200 | 111 | 6 | 907427e85cebe5a18c8a310e2ffa0e180ea3cb77 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 200 | 111 | 6 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.10e-05 | 200 | 111 | 6 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.10e-05 | 200 | 111 | 6 | 8472baa74c48b67c5f08223025885c833458290b | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.01e-05 | 132 | 111 | 5 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Ptrf|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-05 | 133 | 111 | 5 | a1bc34e5dda4ff4716b857931cc196f6770f58f4 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.12e-05 | 65 | 111 | 4 | f14b28214f80ed23501ab28ff254c206f70d77b2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 136 | 111 | 5 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.96e-05 | 143 | 111 | 5 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.48e-05 | 148 | 111 | 5 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.05e-05 | 160 | 111 | 5 | 6c89a2e4189e4f2b6b09b66c6aae6653785ab2f8 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 5.05e-05 | 160 | 111 | 5 | d288b0a315f6adc0be4bdc89fa67bf93679a743f | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.20e-05 | 161 | 111 | 5 | 66554f59eaea4ba55a6c6724f9368e24e99c91e9 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.82e-05 | 84 | 111 | 4 | 9417fffe0ba79f5851920258dcd0f6c09218be13 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.85e-05 | 165 | 111 | 5 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.85e-05 | 165 | 111 | 5 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.19e-05 | 167 | 111 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 168 | 111 | 5 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-05 | 168 | 111 | 5 | 17d46f993dc4ae22b8087808582aba77f5c61892 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.73e-05 | 170 | 111 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Ionocyte|World / Class top | 6.73e-05 | 170 | 111 | 5 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.12e-05 | 172 | 111 | 5 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.12e-05 | 172 | 111 | 5 | 2651dece87c3e3d2d6370f5274ebae357474b825 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.31e-05 | 173 | 111 | 5 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.31e-05 | 173 | 111 | 5 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.72e-05 | 175 | 111 | 5 | 442f261a3b2c4d2523f7d4089178f8c79cac2f0f | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.72e-05 | 175 | 111 | 5 | 35fb7735dd3355476fe60404833cb60bd066bcf1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-05 | 176 | 111 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-05 | 176 | 111 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.93e-05 | 176 | 111 | 5 | 71f96cace3f20fbef975037f4deff9b82b0282a1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.93e-05 | 176 | 111 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.15e-05 | 177 | 111 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.37e-05 | 178 | 111 | 5 | b169aa5eaa51730daaec69c6bc58126be1592a50 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 178 | 111 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.59e-05 | 179 | 111 | 5 | d70791d2a0db35a6b013fa7ed2f9f39364581eff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-05 | 180 | 111 | 5 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.82e-05 | 180 | 111 | 5 | d553aba594f5304f1c09ff9c6d49b64cd7ee7850 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.82e-05 | 180 | 111 | 5 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-05 | 182 | 111 | 5 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.29e-05 | 182 | 111 | 5 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-05 | 183 | 111 | 5 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.78e-05 | 184 | 111 | 5 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.78e-05 | 184 | 111 | 5 | 9e5f98f9113e5e38bdadba6d9d2c346177fb35fe | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.78e-05 | 184 | 111 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 186 | 111 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 186 | 111 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 186 | 111 | 5 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 187 | 111 | 5 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 187 | 111 | 5 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-04 | 187 | 111 | 5 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.05e-04 | 187 | 111 | 5 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 188 | 111 | 5 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-04 | 188 | 111 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 188 | 111 | 5 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 1.08e-04 | 188 | 111 | 5 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 189 | 111 | 5 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 189 | 111 | 5 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 189 | 111 | 5 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.11e-04 | 189 | 111 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.14e-04 | 190 | 111 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 190 | 111 | 5 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.14e-04 | 190 | 111 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 190 | 111 | 5 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 191 | 111 | 5 | e96184aee03175fd9f1da11fa2b89d95ba58b817 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.16e-04 | 191 | 111 | 5 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-04 | 191 | 111 | 5 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.16e-04 | 191 | 111 | 5 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.19e-04 | 192 | 111 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 192 | 111 | 5 | 13e4b17d7a592604140777aca235f795df6b3f91 | |
| Drug | fast white | 2.54e-11 | 42 | 111 | 8 | CID000024008 | |
| Drug | candesartan cilexetil | MYH1 MYH2 MYH3 COL6A3 MYH4 MYH6 MYH7 COL12A1 MYH13 MYH7B TGM4 | 1.31e-10 | 145 | 111 | 11 | CID000002540 |
| Drug | formycin triphosphate | 1.32e-10 | 51 | 111 | 8 | CID000122274 | |
| Drug | purealin | 3.87e-10 | 58 | 111 | 8 | CID006419303 | |
| Drug | AC1N9ZZC | 3.11e-09 | 149 | 111 | 10 | CID004369374 | |
| Drug | NSC339663 | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH13 MYH7B ARF1 PIKFYVE ARR3 CPSF2 | 3.56e-09 | 250 | 111 | 12 | CID000003892 |
| Drug | blebbistatin | 5.53e-09 | 116 | 111 | 9 | CID003476986 | |
| Drug | B0683 | 5.96e-09 | 117 | 111 | 9 | CID006398969 | |
| Drug | SM-2 | 1.05e-08 | 87 | 111 | 8 | CID000486033 | |
| Drug | D-triiodothyronine | MYH1 MYH2 MYH3 COL6A3 MYH4 MYH6 MYH7 MYH13 MYH7B SLC26A4 SLCO1B3 ADH1B ADH1C CFAP20 | 1.26e-08 | 409 | 111 | 14 | CID000000861 |
| Drug | AC1LADJ6 | 1.51e-08 | 130 | 111 | 9 | CID000486032 | |
| Drug | S-(-)-Etomoxir | 3.17e-08 | 100 | 111 | 8 | CID000060765 | |
| Drug | Peony | 3.68e-08 | 20 | 111 | 5 | CID005483934 | |
| Drug | carvedilol | 9.64e-08 | 161 | 111 | 9 | CID000002585 | |
| Drug | 4-Iodopyrazole | 1.13e-07 | 3 | 111 | 3 | DB02721 | |
| Drug | oxovanadium | 1.32e-07 | 120 | 111 | 8 | CID000024411 | |
| Drug | 2bq7 | 1.60e-07 | 123 | 111 | 8 | CID006540267 | |
| Drug | carbachol | CACNA1A MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 HTR1D MYH13 MYH7B TRPC5 LAMA5 PLCD4 PKD1L3 PIKFYVE GUCY2F | 2.30e-07 | 688 | 111 | 16 | CID000002551 |
| Drug | AC1L1J0I | 2.57e-07 | 12 | 111 | 4 | CID000030201 | |
| Drug | cnicin | 3.37e-07 | 92 | 111 | 7 | CID000091176 | |
| Drug | AC1NRBPQ | 3.67e-07 | 137 | 111 | 8 | CID005288569 | |
| Drug | Fomepizole | 4.50e-07 | 4 | 111 | 3 | DB01213 | |
| Drug | clenbuterol | 4.83e-07 | 142 | 111 | 8 | CID000002783 | |
| Drug | 4-chloroaniline | 6.60e-07 | 202 | 111 | 9 | CID000007812 | |
| Drug | pyrophosphate | MYH1 MYH2 MYH3 MYH4 MYH6 CDS1 MYH7 MYH13 MYH7B PLCD4 ADH1B ADH1C SARS1 GUCY2F WDFY3 | 6.77e-07 | 654 | 111 | 15 | CID000001023 |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 7.01e-07 | 15 | 111 | 4 | CID000440673 | |
| Drug | verapamil | CACNA1A MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH13 MYH7B SLC26A4 PKD1L3 KCNH6 AHRR | 8.00e-07 | 490 | 111 | 13 | CID000002520 |
| Drug | Ethanol | 3.89e-06 | 7 | 111 | 3 | DB00898 | |
| Drug | creatine | 4.83e-06 | 193 | 111 | 8 | CID000000586 | |
| Drug | nifedipine | CACNA1A MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH13 MYH7B TRPC5 PKD1L3 | 5.98e-06 | 415 | 111 | 11 | CID000004485 |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; PC3; HT_HG-U133A | 6.05e-06 | 199 | 111 | 8 | 6713_UP | |
| Drug | N-heptylformamide | 6.20e-06 | 8 | 111 | 3 | CID000347402 | |
| Drug | 2-NA | 9.27e-06 | 9 | 111 | 3 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 9.27e-06 | 9 | 111 | 3 | CID000440672 | |
| Drug | dhmal | 1.16e-05 | 29 | 111 | 4 | CID000151725 | |
| Drug | AC1L1AOQ | 1.33e-05 | 30 | 111 | 4 | CID000001082 | |
| Drug | eye gene | 1.34e-05 | 369 | 111 | 10 | CID000004782 | |
| Drug | dicyclohexyl phthalate | CA12 CERK COL6A3 MYH4 ANK2 SLC26A4 PLCD4 ADH1B ADH1C AHRR CADPS SCARB2 ALDH1A3 SLC16A7 SLC26A6 | 1.34e-05 | 836 | 111 | 15 | ctd:C036042 |
| Drug | walrycin A | 1.73e-05 | 32 | 111 | 4 | ctd:C574123 | |
| Drug | AC1L1KMJ | COL6A3 COL12A1 ANK2 MYH7B TRPC5 LAMA5 ARF1 ARF5 PIKFYVE KCNH6 SCARB2 | 2.15e-05 | 476 | 111 | 11 | CID000030956 |
| Drug | nocodazole | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH13 TNFSF10 MYH7B CENPU ARF1 | 2.19e-05 | 477 | 111 | 11 | CID000004122 |
| Drug | hexa-2,4-dien-1-ol | 2.40e-05 | 12 | 111 | 3 | CID000008104 | |
| Drug | 2-butanol | 2.79e-05 | 36 | 111 | 4 | CID000006568 | |
| Drug | trifluoperazine | 3.03e-05 | 324 | 111 | 9 | CID000005566 | |
| Drug | 2-naphthaldehyde | 3.11e-05 | 13 | 111 | 3 | CID000006201 | |
| Drug | 3-methylbutanal | 3.11e-05 | 13 | 111 | 3 | CID000011552 | |
| Drug | N-benzylformamide | 3.53e-05 | 76 | 111 | 5 | CID000080654 | |
| Drug | 2-Propanol | 3.86e-05 | 39 | 111 | 4 | ctd:D019840 | |
| Drug | naphthalenemethanol | 3.95e-05 | 14 | 111 | 3 | CID000020908 | |
| Drug | wartmannin | MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 MYH13 TNFSF10 MYH7B TRPC5 LAMA5 PIKFYVE SCARB2 RAB5B | 4.05e-05 | 811 | 111 | 14 | CID000005691 |
| Drug | dimethyl phthalate | MYH1 CERK ANK2 SLC26A4 ADH1B ADH1C AHRR CADPS SCARB2 NCAPD2 ALDH1A3 SLC16A7 SLC26A6 | 4.54e-05 | 714 | 111 | 13 | ctd:C024629 |
| Drug | S-(+)-ibuprofen [51146-56-6]; Up 200; 19.4uM; PC3; HT_HG-U133A | 4.71e-05 | 194 | 111 | 7 | 6712_UP | |
| Drug | Retinaldehyde | 5.19e-05 | 42 | 111 | 4 | ctd:D012172 | |
| Drug | NSC611747 | 5.77e-05 | 352 | 111 | 9 | CID000002534 | |
| Drug | MgCl2 | 6.02e-05 | 354 | 111 | 9 | CID000024584 | |
| Drug | phenoxyethanol | 6.03e-05 | 16 | 111 | 3 | CID000031236 | |
| Drug | naphthaldehyde | 6.03e-05 | 16 | 111 | 3 | CID000006195 | |
| Drug | monomethyl phthalate | CA12 MYH1 CERK MYH4 ANK2 SLC26A4 PLCD4 ADH1B ADH1C AHRR CADPS SCARB2 ALDH1A3 SLC16A7 SLC26A6 | 6.34e-05 | 957 | 111 | 15 | ctd:C517284 |
| Drug | Sc 58272 | 7.04e-05 | 3 | 111 | 2 | CID000446385 | |
| Drug | CID11968455 | 7.04e-05 | 3 | 111 | 2 | CID011968455 | |
| Drug | 4 OM | 7.04e-05 | 3 | 111 | 2 | CID000001754 | |
| Drug | calfactant | 9.57e-05 | 49 | 111 | 4 | ctd:C117342 | |
| Drug | C x F | 1.03e-04 | 19 | 111 | 3 | CID000013017 | |
| Drug | pentadecane | 1.03e-04 | 19 | 111 | 3 | CID000012391 | |
| Drug | Nile red | 1.04e-04 | 50 | 111 | 4 | CID000065182 | |
| Drug | K-Cl | CACNA1A MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 HTR1D MYH13 MYH7B GUCY2F | 1.04e-04 | 567 | 111 | 11 | CID000004873 |
| Drug | isoproterenol | CACNA1A MYH1 MYH2 MYH3 MYH4 MYH6 MYH7 HTR1D ANK2 MYH13 MYH7B GUCY2F | 1.04e-04 | 669 | 111 | 12 | CID000003779 |
| Drug | NSC3077 | 1.21e-04 | 20 | 111 | 3 | CID000025889 | |
| Drug | NSC9700 | 1.23e-04 | 578 | 111 | 11 | CID000005408 | |
| Drug | AC1L1IZ2 | 1.24e-04 | 304 | 111 | 8 | CID000004795 | |
| Drug | NSC107658 | 1.29e-04 | 306 | 111 | 8 | CID000002919 | |
| Drug | Ethylene Glycol | 1.41e-04 | 21 | 111 | 3 | ctd:D019855 | |
| Drug | 4-iodopyrazole | 1.41e-04 | 21 | 111 | 3 | CID000077022 | |
| Drug | EMSC | 1.41e-04 | 21 | 111 | 3 | CID000093166 | |
| Drug | monoazo | 1.62e-04 | 22 | 111 | 3 | CID000011490 | |
| Drug | cysteinylglycine | 1.73e-04 | 57 | 111 | 4 | CID000065270 | |
| Drug | et E | 1.86e-04 | 23 | 111 | 3 | CID000090263 | |
| Drug | 2-butoxyethanol | 2.12e-04 | 24 | 111 | 3 | CID000008133 | |
| Drug | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 2.12e-04 | 24 | 111 | 3 | ctd:C518860 | |
| Drug | o732 | 2.33e-04 | 5 | 111 | 2 | CID000099589 | |
| Drug | N-1-methylheptylformamide | 2.33e-04 | 5 | 111 | 2 | CID005478865 | |
| Drug | 3-hydroxyundecanoate | 2.33e-04 | 5 | 111 | 2 | CID003083221 | |
| Drug | 3-hydroxynonanoate | 2.33e-04 | 5 | 111 | 2 | CID000036599 | |
| Drug | Ciguatoxins | MYH1 MYH2 MYH4 MYH7 IPO7 SLC26A4 TICAM2 SERPINI2 RAB24 HECTD2 VPS13A CPSF2 SLC16A7 | 2.43e-04 | 845 | 111 | 13 | ctd:D002922 |
| Drug | AC1L1CBF | 2.45e-04 | 336 | 111 | 8 | CID000001822 | |
| Drug | phosphatidate | 2.69e-04 | 432 | 111 | 9 | CID005460104 | |
| Drug | 4-methylpiperazine-2,6-dione | 2.70e-04 | 26 | 111 | 3 | CID000124723 | |
| Drug | fomepizole | 3.03e-04 | 27 | 111 | 3 | ctd:C010238 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.05e-04 | 186 | 111 | 6 | 6671_UP | |
| Drug | AC1OAGFB | 3.09e-04 | 539 | 111 | 10 | CID006857345 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.02e-18 | 10 | 107 | 8 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.02e-18 | 10 | 107 | 8 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.02e-18 | 10 | 107 | 8 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.02e-18 | 10 | 107 | 8 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.02e-18 | 10 | 107 | 8 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.02e-18 | 10 | 107 | 8 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.02e-18 | 10 | 107 | 8 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.02e-18 | 10 | 107 | 8 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.12e-17 | 12 | 107 | 8 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.12e-17 | 12 | 107 | 8 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.90e-17 | 13 | 107 | 8 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.44e-16 | 15 | 107 | 8 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 7.67e-12 | 48 | 107 | 8 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.02e-10 | 71 | 107 | 8 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 5.35e-10 | 80 | 107 | 8 | DOID:12930 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.56e-06 | 8 | 107 | 3 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 1.30e-05 | 2 | 107 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 1.30e-05 | 2 | 107 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 3.90e-05 | 3 | 107 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 3.90e-05 | 3 | 107 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | neuroblastoma | 6.65e-05 | 116 | 107 | 5 | EFO_0000621 | |
| Disease | Ullrich congenital muscular dystrophy | 7.78e-05 | 4 | 107 | 2 | cv:C4551860 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 7.78e-05 | 4 | 107 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 7.78e-05 | 4 | 107 | 2 | cv:C3495498 | |
| Disease | Bethlem myopathy | 7.78e-05 | 4 | 107 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 7.78e-05 | 4 | 107 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 7.78e-05 | 4 | 107 | 2 | C0410179 | |
| Disease | longitudinal BMI measurement, non-small cell lung carcinoma | 7.78e-05 | 4 | 107 | 2 | EFO_0003060, EFO_0005937 | |
| Disease | Caveolinopathy | 7.78e-05 | 4 | 107 | 2 | cv:C5679790 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 7.78e-05 | 4 | 107 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 7.78e-05 | 4 | 107 | 2 | 192600 | |
| Disease | Bethlem myopathy (is_implicated_in) | 7.78e-05 | 4 | 107 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 7.78e-05 | 4 | 107 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | sick sinus syndrome (is_implicated_in) | 1.29e-04 | 5 | 107 | 2 | DOID:13884 (is_implicated_in) | |
| Disease | Alcohol dependence | 1.29e-04 | 5 | 107 | 2 | cv:C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 1.29e-04 | 5 | 107 | 2 | 103780 | |
| Disease | lumbar disc degeneration | 1.42e-04 | 28 | 107 | 3 | EFO_0004994 | |
| Disease | REM sleep behavior disorder | 1.94e-04 | 6 | 107 | 2 | EFO_0007462 | |
| Disease | protein CASC4 measurement | 1.94e-04 | 6 | 107 | 2 | EFO_0802927 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 2.70e-04 | 7 | 107 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 2.70e-04 | 7 | 107 | 2 | C0700053 | |
| Disease | Obstructive asymmetric septal hypertrophy | 2.70e-04 | 7 | 107 | 2 | C0597124 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 3.29e-04 | 37 | 107 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | Lung Neoplasms | 4.20e-04 | 265 | 107 | 6 | C0024121 | |
| Disease | Malignant neoplasm of lung | 4.29e-04 | 266 | 107 | 6 | C0242379 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 4.61e-04 | 9 | 107 | 2 | C0949658 | |
| Disease | hydroxyproline measurement | 5.75e-04 | 10 | 107 | 2 | EFO_0010498 | |
| Disease | glucagon-like peptide-1 measurement | 5.75e-04 | 10 | 107 | 2 | EFO_0008465 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 5.75e-04 | 10 | 107 | 2 | cv:C5675009 | |
| Disease | pulmonary emphysema (implicated_via_orthology) | 9.90e-04 | 13 | 107 | 2 | DOID:9675 (implicated_via_orthology) | |
| Disease | alcohol dependence measurement | 1.06e-03 | 55 | 107 | 3 | EFO_0007835 | |
| Disease | ecosanoids measurement | 1.06e-03 | 55 | 107 | 3 | EFO_0020044 | |
| Disease | Left ventricular noncompaction | 1.15e-03 | 14 | 107 | 2 | C1960469 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.32e-03 | 222 | 107 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | C-reactive protein measurement | MYH2 RAB35 DMXL2 VPS13C SPG11 CACHD1 ADH1B ADH1C EXOC6B CAMTA1 GALNT4 USP47 | 1.43e-03 | 1206 | 107 | 12 | EFO_0004458 |
| Disease | alcohol use disorder (is_implicated_in) | 1.51e-03 | 16 | 107 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | response to radiation, Urinary retention | 1.71e-03 | 17 | 107 | 2 | GO_0009314, HP_0000016 | |
| Disease | alcohol consumption measurement | CACNA1A COL12A1 MCHR2 PKD1L3 ARF3 ADH1A ADH1B ADH1C CADPS CAMTA1 CSMD1 SLC16A7 | 1.83e-03 | 1242 | 107 | 12 | EFO_0007878 |
| Disease | Alcohol abuse | 1.88e-03 | 67 | 107 | 3 | C0085762 | |
| Disease | Contact Dermatitis | 2.22e-03 | 71 | 107 | 3 | C0011616 | |
| Disease | Contact hypersensitivity | 2.22e-03 | 71 | 107 | 3 | C0162351 | |
| Disease | haptoglobin measurement | 2.62e-03 | 21 | 107 | 2 | EFO_0004640 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 2.62e-03 | 21 | 107 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 2.87e-03 | 22 | 107 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | Primary familial hypertrophic cardiomyopathy | 2.87e-03 | 22 | 107 | 2 | cv:C0949658 | |
| Disease | epilepsy (implicated_via_orthology) | 2.98e-03 | 163 | 107 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Sensorineural Hearing Loss (disorder) | 3.14e-03 | 23 | 107 | 2 | C0018784 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 3.41e-03 | 24 | 107 | 2 | EFO_0009458, MONDO_0007079 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYLRVKSFFQVVQEQ | 76 | A9YTQ3 | |
| VAYENALRVFNIVFT | 1591 | O00555 | |
| EEQRAKFQSFVVTYV | 416 | Q9P2K9 | |
| VDDVFVFINTYRQAT | 531 | Q9P2K9 | |
| NQIISNSVVFEYKAR | 941 | Q9Y6Y1 | |
| TVADYFATFVQREEQ | 161 | Q92903 | |
| IKITFDRFQTEVNYD | 796 | Q96PZ7 | |
| NYNITIFVDTFQSEK | 2356 | Q96PZ7 | |
| NVSYNVVEFSKSQVE | 271 | Q9P2I0 | |
| QVAQDTEEVFRSYVF | 26 | Q16611 | |
| ELYRVFTTQELVQAF | 221 | O95433 | |
| TFSQYTVVDENAVAK | 146 | P07327 | |
| ITIIAFAQYVQEATF | 46 | P43652 | |
| TFSQYTVVDENAVAK | 146 | P00325 | |
| TFSQYTVVDENAVAK | 146 | P00326 | |
| FNVETVEYKNICFTV | 51 | P84085 | |
| AASRVFVEEQVYSEF | 316 | P47895 | |
| FVEEQVYSEFVRRSV | 321 | P47895 | |
| QRIFNSFVYTEKISN | 66 | Q5VU97 | |
| AAIATFYVNVKEQFI | 276 | Q71F23 | |
| FNVETVEYKNISFTV | 51 | P61204 | |
| QEVLQETFIRYIFTK | 2621 | Q8TDJ6 | |
| YTKTVFIQEFTETVA | 246 | P36575 | |
| VTLEVVKFTQAYFIN | 361 | Q9Y2Q0 | |
| RNISNYFTFIKDQTV | 2366 | Q6ZS30 | |
| QKVAEDYVSVAAFQV | 166 | Q969Q5 | |
| VVYDVTSAESFVNVK | 86 | Q15286 | |
| AIVVYDITNQETFAR | 96 | P61020 | |
| LENAQKSFETTVRYF | 1321 | Q68DA7 | |
| FRQRSQAEDVATYKV | 276 | Q92830 | |
| YFQEQTKDSVRQIIF | 81 | Q96N11 | |
| VNTKRVIQYFAVIAA | 186 | P12883 | |
| DYEAIQDFQFVVKAT | 521 | Q9Y5F3 | |
| SVQAYETQVKFIFEL | 471 | Q6GTS8 | |
| EEVQFQPVVSKQYTF | 2706 | Q01484 | |
| AAYEVNSRDTVFIFK | 341 | P09238 | |
| KRFFVLVQVSQYTFA | 541 | Q9ULU8 | |
| RVAVVNYASTVKIEF | 121 | O15232 | |
| FEYGRKVNIVTQEIF | 3111 | Q5T1H1 | |
| VVVVAKTTRYEFEQQ | 71 | Q4G0N4 | |
| KREQYSDFNQVFTFI | 481 | P59045 | |
| YFTFEVQVLDDKNVR | 86 | Q9Y6A4 | |
| YSTFQVFQEEFGIIK | 581 | Q5U5R9 | |
| FVVDIVINFRTTYVN | 311 | Q9H252 | |
| ETVDKISNFVYEQFI | 5346 | Q5CZC0 | |
| QVQKFDERLVYTSFS | 276 | O43570 | |
| TVNTKRVIQYFAIVA | 226 | A7E2Y1 | |
| VDEYQIFKAIFQTIQ | 956 | O95373 | |
| TVNTKRVIQYFATIA | 186 | Q9UKX2 | |
| VQLTDFENSAYVVFV | 431 | P48506 | |
| TVFFKEIQQIFHTTY | 41 | O60669 | |
| TVNTKRVIQYFATIA | 186 | P12882 | |
| RKYFNQIVGFFVVED | 341 | Q9Y2D4 | |
| SINFNKVVSVFYSVV | 271 | Q8NGQ2 | |
| NEEVVSLYNFERTFQ | 2906 | O15230 | |
| TAFYNNAEVFEVVER | 916 | P42694 | |
| QATRAYIQEFQEFSK | 51 | Q6UWY5 | |
| NKEFAYQTASVVDTV | 21 | Q969V1 | |
| FFQKVSQVYVAIDER | 1416 | Q9Y2I7 | |
| NRDEVFQYFISKVRQ | 2556 | Q9C0G6 | |
| LVYQTRVFEFDVINS | 3816 | Q4G0P3 | |
| YAAKVIFRNEVTNEF | 4806 | Q4G0P3 | |
| QTVTFDTEEVKTLFY | 2631 | Q99715 | |
| RQYVVQVIFSVTFAF | 36 | B7ZAQ6 | |
| RQYVVQVIFSVTFAF | 36 | P0CG08 | |
| QQDQFDFTFVEVYRV | 441 | Q8TCT0 | |
| FEYTSNKEIRFNSVT | 486 | Q8N4A0 | |
| VESQEKTFYQAFTEA | 316 | P51841 | |
| AVVTYNNEVTTEIRF | 2446 | P12111 | |
| VNYNVTTEFEKRAQR | 156 | Q8IXQ4 | |
| YTVFNEEFRQAFQKI | 356 | P28221 | |
| FNVETVEYKNISFTV | 51 | P84077 | |
| TLQEVQEDFVFSKYR | 381 | Q99698 | |
| EFSQTVGEVFYTKNR | 131 | Q53GD3 | |
| QELYFSTVDTFQKFV | 521 | P57679 | |
| TVTRAYKVNTDINFE | 161 | Q9NQL2 | |
| EKYAFSENTFNRQII | 51 | Q9P1A2 | |
| AYQVRSITFAREFQV | 96 | Q9HBV1 | |
| VTFSVIFAYVADVTQ | 146 | Q5SR56 | |
| FRVHQFEKIEQFVYS | 316 | P49591 | |
| TKNESEIQFFYVDVS | 121 | Q8NBJ9 | |
| NSFYVVVVVKTEDQA | 241 | Q8NBJ9 | |
| KDVVATVAQYAFQTS | 361 | Q9BRC7 | |
| AAAVQVFVSQLKYVF | 221 | Q9BXS9 | |
| QDRFISFYEAVKVNS | 1536 | Q7Z443 | |
| AVSNKAYVFERDQSV | 111 | Q14108 | |
| TVNTKRVIQYFATIA | 186 | Q9Y623 | |
| TVNTKRVIQYFATIA | 186 | P11055 | |
| VERIFQESVYKTQQT | 206 | Q86XR7 | |
| IFIVYDTRFVFSEVN | 376 | P49221 | |
| AVNIKTAEIYRASFQ | 181 | Q96AB6 | |
| VNTKRVIQYFASIAA | 186 | P13533 | |
| DFYTNRTVQIAAVVD | 101 | P12273 | |
| EKEYVNIQTFRFFVG | 231 | Q01968 | |
| FNVETVEYKNICFTV | 51 | P18085 | |
| TVAAELAIFRVFNKY | 1356 | Q8N3C0 | |
| QRKVVEFTCQTAFFV | 916 | Q13733 | |
| YENTTTVVQEVIEFF | 646 | Q15021 | |
| FYTTNKNIRDFLVEI | 761 | Q96JI7 | |
| QVQSFREKIAYFTRA | 1166 | Q6AWC2 | |
| IIYDARTVNSIVEFF | 591 | Q96RL7 | |
| LVNNVFYFTQRVVDK | 2041 | Q8IZQ1 | |
| KEFQRIDVNVYFASL | 681 | O43511 | |
| TRKFFIYVAIQVINS | 531 | Q9NPD5 | |
| KVFRVYASNQEFESV | 1081 | Q96K76 | |
| TVNTKRVIQYFATIA | 186 | Q9UKX3 | |
| RTVFQFDVQRKYFKE | 271 | O43847 | |
| CNVAFEKQVAVRYTF | 196 | O95685 | |
| VYVSQVTQKVFFEIN | 326 | O75830 | |
| YDAKTVNAVVEFFQS | 636 | Q709C8 | |
| QEAVVFEDVAVYFTR | 11 | Q6ZMY9 | |
| EYVEAVSFQHFIKTR | 126 | Q99598 | |
| VVKRFQEDEYQDSTF | 41 | Q8TBZ5 | |
| YVTNVKARHEFTEFV | 586 | Q9UL62 | |
| SQTYFRFQEEIKENT | 186 | P50591 | |
| VSVTIERVKDFSYNF | 316 | O00206 |